# Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)

> **NCT01318330** · PHASE1 · COMPLETED · sponsor: **HomeoTherapy Co., Ltd** · enrollment: 10 (estimated)

## Conditions studied

- Graft-vs-Host Disease

## Interventions

- **DRUG:** Homeo-GH

## Key facts

- **NCT ID:** NCT01318330
- **Lead sponsor:** HomeoTherapy Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-12
- **Final completion:** 2012-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2012-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01318330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01318330, "Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01318330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*